0.212
Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.30 | - | - | - |
| Operating Expenses |
35.76%
3.295
|
2.427 | 2.063 | 4.44 | 13.13 |
| Operating Income/Loss |
54.91%
-3.295
|
-2.127 | -2.063 | -4.44 | -13.13 |
| Nonoperating Income/Loss |
6.02%
0.078
|
0.083 | 0.067 | 0.079 | 0.074 |
| Income/Loss From Continuing Operations Before Tax |
57.39%
-3.217
|
-2.044 | -1.996 | -4.361 | -13.06 |
| Net Income/Loss |
57.39%
-3.217
|
-2.044 | -1.996 | -4.361 | -13.06 |
| Basic Average Shares |
11.74%
45.89
|
41.07 | - | 9.6765 | 6.753 |
| Diluted Average Shares |
11.74%
45.89
|
41.07 | - | 9.6765 | 6.753 |
| Basic Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | -0.45 | -1.93 |
| Diluted Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | -0.45 | -1.93 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):